{"text": "The two FTD patients under investigation in this study were part of a longitudinal dementia research program at the Memory and Aging Center, University of California, San Francisco.", "sentId": 1, "start": 0, "end": 181}
{"text": "Both had an 8-year history of behavioral changes and memory impairment at the time of tissue collection for this study.", "sentId": 2, "start": 182, "end": 301}
{"text": "One patient, a 67-year-old male with sporadic FTD, tested negative for mutations in GRN, MAPT, and C9ORF72.", "sentId": 3, "start": 302, "end": 409}
{"text": "The other patient, a 64-year-old male with a significant family history of dementia, had behavioral variant FTD.", "sentId": 4, "start": 410, "end": 522}
{"text": "MRI in this patient demonstrated severe bifrontal and temporal atrophy associated with gliosis in the frontal lobes (greater on the right).", "sentId": 5, "start": 523, "end": 662}
{"text": "One year later, MRI scans showed progression of atrophy and gliosis.", "sentId": 6, "start": 663, "end": 731}
{"text": "Genetic testing revealed a novel nonsense mutation in GRN, p.S116X (g.4627C > A, c.347C > A), which is predicted to result in a premature stop codon.", "sentId": 7, "start": 732, "end": 881}
{"text": "Both FTD patients had parkinsonism, which is typical of all FTD patients with PGRN mutations.", "sentId": 8, "start": 882, "end": 975}
{"text": "An age-matched subject, a clinically normal 64-year-old male with no mutations in GRN, MAPT, or C9ORF72, served as a control.", "sentId": 9, "start": 976, "end": 1101}
